The DOI matches its Crossref record.
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
Abstract
Objective To determine the value of serum screening for Down's syndrome at 8–14 weeks of pregnancy using seven potential serum markers (alpha‐fetoprotein, unconjugated oestriol, total human chorionic gonadotrophin (hCG), free α‐hCG, free P‐hCG, pregnancy associated plasma protein A (PAPP‐A), and dimeric inhibin A). Design Stored blood samples collected from women at about 10 weeks of pregnancy, prior to having a chorionic villus sampling procedure on account of advanced maternal age, were retrieved from pregnancies associated with Down's syndrome and from matched unaffected pregnancies. Setting Twenty‐one obstetric centres in nine countries. Subjects Seventy‐seven pregnancies associated with Down's syndrome each matched with five controls (except in two cases that were matched with four controls) for maternal age (same five year age groups), duration of storage of the serum sample (same calendar year), and gestational age (usually same week of pregnancy). Results The levels of two potential markers differed between affected and unaffected pregnancies sufficiently to be of value in screening—free β‐hCG and PAPP‐A. The median free P‐hCG level in affected pregnancies was 1.79 times the median level for unaffected pregnancies, and the median PAPP‐A level was 0.43 times the normal median. These two markers were combined with maternal age to estimate a woman's risk of having a fetus with Down's syndrome. A screening programme that used a risk cutoff level of 1:300 would detect 63 % of affected pregnancies and also classify 5.5% of unaffected pregnancies as screen positive. None of the other five markers added more than 2 % detection for the same false‐positive rate. Conclusion The performance of screening using maternal age and serum‐free β‐hCG and PAPP‐A at 10 weeks of pregnancy was better than the double test (alpha‐fetoprotein and hCG with maternal age) and similar to the triple test (alpha‐fetoprotein, unconjugated oestriol and hCG with maternal age) at 15–22 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., Hays, L. G., Yates, J. R., & Conover, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3149 · Cited by 706
Spencer, K., Souter, V., Tul, N., Snijders, R., & Nicolaides, K. H. (1999) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1999.13040231.x · Cited by 568
Wald, N. J., Watt, H. C., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 530
Self-citationAlldred, S. K., Takwoingi, Y., Guo, B., Pennant, M., Deeks, J. J., Neilson, J. P., & Alfirevic, Z. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012599 · Cited by 529
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 426
Metadata
- Authors
- Wald, N. J., George, L., Smith, D., Densem, J. W., Pettersonm, K., & on behalf of the International Prenatal Screening Research Group
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 1996-05
- Volume
- 103
- Issue
- 5
- Pages
- 407-412
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W2098252458
- Cited by
- 199
- References
- 0
- FWCI
- 24.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. https://app.cochat.ai/papers/10.1111/j.1471-0528.1996.tb09765.x
- The paper
- Wald, N. J., George, L., Smith, D., Densem, J. W., Pettersonm, K., & on behalf of the International Prenatal Screening Research Group. (1996). Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.1996.tb09765.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.